MANCHESTER, England, March 10, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, announced that it has ...
Haduvio met the primary endpoint with a statistically-significant reduction (p0.0001) in 24-hour cough frequency with a 57% placebo-adjusted change from baseline Company to host a conference call and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback